Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-9172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis ; volume:12 ; number:2 ; day:24 ; month:12 ; year:2021 ; pages:451-466 ; date:2.2022
Dermatology and therapy ; 12, Heft 2 (24.12.2021), 451-466, 2.2022
- Creator
-
Tanaka, Masayuki
Ozeki, Yasushi
Matsuyama, Fujio
Murata, Tatsunori
Imafuku, Shinichi
Nakamura, Taichi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-021-00659-w
- URN
-
urn:nbn:de:101:1-2022060402482151362030
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tanaka, Masayuki
- Ozeki, Yasushi
- Matsuyama, Fujio
- Murata, Tatsunori
- Imafuku, Shinichi
- Nakamura, Taichi
- SpringerLink (Online service)
Other Objects (12)
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Biologic treatment of Japanese patients with inflammatory bowel disease
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy
Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study
Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago
Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Biologic treatment of Japanese patients with inflammatory bowel disease
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy
Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study
Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago
Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Biologic treatment of Japanese patients with inflammatory bowel disease
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy
Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study
Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago